Efficacy and Safety of Alogliptin Compared to Glipizide in Elderly Diabetics

NCT00707993 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

441

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus

Interventions

DRUG: Alogliptin
DRUG: Glipizide

Sponsor

Takeda